References
Lu C, Qiu Z, Sun M, Wang W, Wei M, Zhang X (2016) Spectrum of AGL mutations in Chinese patients with glycogen storage disease type III: identification of 31 novel mutations. J Hum Genet 61:641–645. https://doi.org/10.1038/jhg.2016.24
Sentner CP, Hoogeveen IJ, Weinstein DA, Santer R, Murphy E, McKiernan PJ, Steuerwald U, Beauchamp NJ, Taybert J, Laforêt P, Petit FM, Hubert A, Labrune P, Smit GPA, Derks TGJ (2016) Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome. J Inherit Metab Dis 39:697–704. https://doi.org/10.1007/s10545-016-9932-2
Decostre V, Laforêt P, Nadaj-Pakleza A, de Antonio M, Leveugle S, Ollivier G, Canal A, Kachetel K, Petit F, Eymard B, Behin A, Wahbi K, Labrune P, Hogrel JY (2016) Cross-sectional retrospective study of muscle function in patients with glycogen storage disease type III. Neuromuscul Disord 6:584–592. https://doi.org/10.1016/j.nmd.2016.06.460
Yu Z, Mingming X, Xiaoxia C et al (2018) Genetic analysis and clinical assessment of four patients with glycogen storage disease type IIIa in China. BMC Med Genet 19:54. https://doi.org/10.1186/s12881-018-0560-6
Hobson-Webb LD, Austin SL, Bali DS, Kishnani PS (2010) The electrodiagnostic characteristics of glycogen storage disease type III. Genet Med 12:440–445. https://doi.org/10.1097/GIM.0b013e3181cd735b
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Informed consent was obtained from the patient.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Li, Y., Qi, X., Zhang, W. et al. A novel homozygous splicing mutation of the AGL gene in a Chinese patient with severe myopathy involvement of glycogen storage disease type IIIa. Neurol Sci 42, 1623–1625 (2021). https://doi.org/10.1007/s10072-020-04883-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-020-04883-8